Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Taiwanese Journal of Obstetrics & Gynecology
|
March 2, 2016
Clinical parameters associated with absence of endocervical/transformation zone component in conventional cervical Papanicolaou smears
Lou Sun, Peng-Hui Wang, Chen-Hui Lee, et al.
Journal of Clinical Medicine
|
January 23, 2024
Maintenance Chemotherapy in Patients with Platinum-Sensitive Relapsed Epithelial Ovarian Cancer after Second-Line Chemotherapy
Yen-Fu Chen, Shih-Tien Hsu, Sheau-Feng Hwang, et al.
Frontiers in Oncology
|
June 6, 2022
Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer
Jo-Ni Hung, Shih-Tien Hsu, Lou Sun, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 28, 2019
Do-not-resuscitate status is correlated with the prescribed use of systemic strong opioid analgesics in patients with terminal cancer: an observational study
Chun-Li Wang, Chia-Yen Lin, Chun-Che Huang, et al.
BMC Medicine
|
February 21, 2025
A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma
Ting-Fang Lu, Lou Sun, Yu-Hsiang Shih, et al.
BMC Medicine
|
March 15, 2025
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
Shao-Jing Wang, Lou Sun, Yu-Hsiang Shih, et al.
Journal of Clinical Medicine
|
October 16, 2024
Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus Paclitaxel
Shao-Jing Wang, Hsin-Hua Chen, Lou Sun, et al.
Journal of Clinical Medicine
|
January 21, 2023
Improved Progression-Free Survival Associated with Tumor-Infiltrating Lymphocytes in High-Grade Endometrial Cancer
Chun-Ting Fan, Shih-Tien Hsu, Lou Sun, et al.
Frontiers in Oncology
|
December 13, 2023
Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcoma
Szu-Yun Niu, Lou Sun, Shih-Tien Hsu, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Taiwanese Journal of Obstetrics & Gynecology
|
March 2, 2016
Clinical parameters associated with absence of endocervical/transformation zone component in conventional cervical Papanicolaou smears
Lou Sun, Peng-Hui Wang, Chen-Hui Lee, et al.
Journal of Clinical Medicine
|
January 23, 2024
Maintenance Chemotherapy in Patients with Platinum-Sensitive Relapsed Epithelial Ovarian Cancer after Second-Line Chemotherapy
Yen-Fu Chen, Shih-Tien Hsu, Sheau-Feng Hwang, et al.
Frontiers in Oncology
|
June 6, 2022
Real-World Efficacy of Bevacizumab in Patients With Recurrent Epithelial Ovarian Cancer
Jo-Ni Hung, Shih-Tien Hsu, Lou Sun, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
March 28, 2019
Do-not-resuscitate status is correlated with the prescribed use of systemic strong opioid analgesics in patients with terminal cancer: an observational study
Chun-Li Wang, Chia-Yen Lin, Chun-Che Huang, et al.
BMC Medicine
|
February 21, 2025
A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma
Ting-Fang Lu, Lou Sun, Yu-Hsiang Shih, et al.
BMC Medicine
|
March 15, 2025
Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer
Shao-Jing Wang, Lou Sun, Yu-Hsiang Shih, et al.
Journal of Clinical Medicine
|
October 16, 2024
Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus Paclitaxel
Shao-Jing Wang, Hsin-Hua Chen, Lou Sun, et al.
Journal of Clinical Medicine
|
January 21, 2023
Improved Progression-Free Survival Associated with Tumor-Infiltrating Lymphocytes in High-Grade Endometrial Cancer
Chun-Ting Fan, Shih-Tien Hsu, Lou Sun, et al.
Frontiers in Oncology
|
December 13, 2023
Efficacy and toxicities of doxorubicin plus ifosfamide in the second-line treatment of uterine leiomyosarcoma
Szu-Yun Niu, Lou Sun, Shih-Tien Hsu, et al.
Page
of 2